UPDATE 1-Merck's Gardasil wins US approval for anal cancer

NEW YORK, Dec 22 (Reuters) - Merck & Co's Gardasil vaccine won U.S. approval on Wednesday for preventing anal cancer, expanding the product's use.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.